Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited (TLX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TLX · as of Sep 30, 2025
Ownership Breakdown
27
Institutional Holders
▲ 6 vs Q2
$7.88M
Total Inst. Value
▲ $591,957 vs Q2
338.78M
Shares Outstanding
freeFloat 80.51%
823,173
13F Shares Held
▲ 370,707 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TLX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 196.7K | 5.83% | 5.83% | $1.88B | Nov 14, 2025 | NEW |
PORTLAND INVESTMENT COUNSEL INC. pharmaceutical preparations | 128.0K | 3.80% | 3.80% | $1.22B | Nov 13, 2025 | NEW |
FMR LLC pharmaceutical preparations | 118.5K | 3.51% | 3.51% | $1.13B | Nov 13, 2025 | ▲ 76.4K |
LAZARD ASSET MANAGEMENT LLC pharmaceutical preparations | 114.6K | 3.40% | 3.40% | $1.10B | Nov 14, 2025 | NEW |
JANE STREET GROUP, LLC pharmaceutical preparations | 73.0K | 2.16% | 2.16% | $698.53M | Nov 14, 2025 | ▲ 37.9K |
MARSHALL WACE, LLP pharmaceutical preparations | 48.6K | 1.44% | 1.44% | $464.84M | Nov 13, 2025 | NEW |
PRIVATE ADVISOR GROUP, LLC pharmaceutical preparations | 42.1K | 1.25% | 1.25% | $403.02M | Nov 13, 2025 | ▲ 16.9K |
IHT WEALTH MANAGEMENT, LLC pharmaceutical preparations | 26.2K | 0.78% | 0.78% | $250.82M | Nov 14, 2025 | ▲ 13.0K |
JPMORGAN CHASE & CO pharmaceutical preparations | 25.4K | 0.75% | 0.75% | $242.65M | Nov 26, 2025 | NEW |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC pharmaceutical preparations | 18.4K | 0.55% | 0.55% | $175.88M | Oct 31, 2025 | ▼ 97 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
8
Increased
+146.0K shares13
New Positions
first time holders4
Decreased
−1.8K shares7
Sold Out
fully exitedNet shares change (top 50)
+144.1K
+146.0K / −1.8K
Net new holders
+10
13 new / 7 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TLX insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Behrenbruch Christian MD & Group CEO | Apr 29, 2026 | Purchase | 33,435 | $14.87 | $497.2K | 20.74M | Form 4 ↗ |
Behrenbruch Christian MD & Group CEO | Apr 28, 2026 | Purchase | 34,500 | $14.48 | $499.6K | 20.71M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Telix Pharmaceuticals Limited (TLX) is primarily owned by institutional investors, who hold approximately 0.2% of total shares outstanding. Company insiders own approximately 19.49%, while retail and public investors account for the remaining 80.26%.
The largest institutional shareholder of Telix Pharmaceuticals Limited is MILLENNIUM MANAGEMENT LLC, holding approximately 196,741 shares — equal to 5.83% of outstanding shares — as of September 30, 2025.
A total of 27 institutional investors currently hold TLX stock, with a combined institutional value of approximately $7,877,366 as of the most recent 13F filing period.
Frequently asked questions
TLX ownershipTelix Pharmaceuticals Limited (TLX) is primarily owned by institutional investors, who hold approximately 0.2% of shares. The largest shareholder is MILLENNIUM MANAGEMENT LLC with a 5.83% stake. Company insiders hold 19.49%. Data sourced from SEC Form 13F as of September 30, 2025.